| Formulation and stabilization of recombinant protein based virus-like particle vaccines NK Jain, N Sahni, OS Kumru, SB Joshi, DB Volkin, CR Middaugh Advanced drug delivery reviews 93, 42-55, 2015 | 99 | 2015 |
| A biophysical map of the dystrophin rod A Mirza, M Sagathevan, N Sahni, L Choi, N Menhart Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1804 (9), 1796-1809, 2010 | 42 | 2010 |
| Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants KJ Hassett, DJ Vance, NK Jain, N Sahni, LA Rabia, MC Cousins, S Joshi, ... Journal of pharmaceutical sciences 104 (2), 627-639, 2015 | 35 | 2015 |
| Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions RM Kramer, Y Zeng, N Sahni, LA Kueltzo, RM Schwartz, IK Srivastava, ... Journal of pharmaceutical sciences 102 (12), 4305-4314, 2013 | 28 | 2013 |
| Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies SV Thakkar, N Sahni, SB Joshi, BA Kerwin, F He, DB Volkin, ... Protein Science 22 (10), 1295-1305, 2013 | 23 | 2013 |
| Recombinant subunit rotavirus trivalent vaccine candidate: physicochemical comparisons and stability evaluations of three protein antigens S Agarwal, JM Hickey, N Sahni, RT Toth IV, GA Robertson, R Sitrin, ... Journal of pharmaceutical sciences 109 (1), 380-393, 2020 | 19 | 2020 |
| Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant VM Toprani, N Sahni, JM Hickey, GA Robertson, CR Middaugh, SB Joshi, ... Vaccine 35 (41), 5471-5480, 2017 | 18 | 2017 |
| Characterizing and minimizing aggregation and particle formation of three recombinant fusion-protein bulk antigens for use in a candidate trivalent rotavirus vaccine S Agarwal, N Sahni, JM Hickey, GA Robertson, R Sitrin, S Cryz, SB Joshi, ... Journal of pharmaceutical sciences 109 (1), 394-406, 2020 | 17 | 2020 |
| Exon edited dystrophin rods in the hinge 3 region N Sahni, K Mangat, E Le Rumeur, N Menhart Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (10), 1080-1089, 2012 | 16 | 2012 |
| Structural characterization and physicochemical stability profile of a double mutant heat labile toxin protein based adjuvant VM Toprani, JM Hickey, N Sahni, RT Toth IV, GA Robertson, ... Journal of Pharmaceutical Sciences 106 (12), 3474-3485, 2017 | 9 | 2017 |
| Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms JM Hickey, N Sahni, RT Toth IV, OS Kumru, SB Joshi, CR Middaugh, ... Journal of Chromatography B 1032, 23-38, 2016 | 9 | 2016 |
| Vaccine delivery: Current routes of administration and novel approaches N Sahni, Y Cheng, CR Middaugh, DB Volkin Drug Delivery: Principles and Applications, 623-654, 2016 | 7 | 2016 |
| Preformulation characterization, stabilization, and formulation design for the acrylodan-labeled glucose-binding protein SM4-AC N Sahni, R Chaudhuri, JM Hickey, P Manikwar, A D’Souza, A Metters, ... Journal of Pharmaceutical Sciences 106 (5), 1197-1210, 2017 | 4 | 2017 |
| Effect of acrylodan conjugation and forced oxidation on the structural integrity, conformational stability, and binding activity of a glucose binding protein SM4 used in a … JM Hickey, N Sahni, R Chaudhuri, A D'Souza, A Metters, SB Joshi, ... Protein Science 26 (3), 527-535, 2017 | 4 | 2017 |
| Structure and function of Native and edited dystrophin rods N Sahni Illinois Institute of Technology, 2011 | | 2011 |
